DONDERO, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 4.696
Totale 4.696
Nazione #
IT - Italia 4.696
Totale 4.696
Città #
Genova 3.237
Genoa 591
Rapallo 444
Vado Ligure 405
Bordighera 19
Totale 4.696
Nome #
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 192
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 189
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 173
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 163
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 162
Main NK cell receptors and their ligands: regulation by microRNAs 153
Multi-directional cross-regulation of NK cell function during innate immune responses. 142
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 142
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. 130
Human NK cells and NK receptors 129
CIS is a negative regulator of IL-15-mediated signals in NK cells 128
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 127
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 125
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 122
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. 122
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 122
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 115
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 114
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. 114
Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies 113
Neuroblastoma-derived transforming growth factor (TGF) β1 modulates the chemokine receptor repertoire of human resting Natural Killer Cells. 112
Expression of the DNAM-1 ligands Nectin-2 (CD112) and poliovirus receptor (CD155) on dendritic cells: relevance for natural killer/dendritic cells interaction 111
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1 110
Neuroblastoma-Derived TGF-beta1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells. 109
It's only innate immunity but I like it 109
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 108
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 107
Neuroblastoma Cells Modulate Chemokine Receptor Repertoire of Resting NK Cells 102
Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily 101
TGF-beta1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells 96
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma 96
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 90
IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules 88
Su.64. Natural Killer Cell-mediated Recognition of Human Brain Tumors 88
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 86
Identification of a novel neuroblastoma-associated molecule that protects from NK-mediated lysis 86
Natural Killer cells recognize and kill human glioblastoma cells with stem cell-like properties 75
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine /chemokine secretion in CD56(bright) and CD56(dim) NK cells 58
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies 55
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants 49
Inhibitory axes impacting on the activity and fate of Innate Lymphoid Cells 49
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model 46
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms 46
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants 34
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma 33
miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells 21
Totale 4.842
Categoria #
all - tutte 15.193
article - articoli 14.548
book - libri 0
conference - conferenze 253
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 392
Totale 30.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020537 0 0 0 0 0 0 0 85 107 193 116 36
2020/2021458 23 50 53 32 21 72 10 39 30 59 21 48
2021/2022522 28 31 45 60 10 40 25 115 31 47 28 62
2022/2023541 54 50 6 57 80 94 3 36 105 4 39 13
2023/2024331 17 48 12 55 14 31 15 30 26 12 30 41
2024/2025597 14 62 51 55 138 98 108 71 0 0 0 0
Totale 4.842